person reading Mr. Jeffrey W. Albers, J.D.'s salary history.

Historical salary details - Mr. Jeffrey W. Albers, J.D., Independent Director, Kymera Therapeutics Inc

Mr. Jeffrey W. Albers, J.D. is the Independent Director of Kymera Therapeutics Inc. They also hold 2 other positions in Blueprint Medicines Corp and Spyre Therapeutics Inc..

Mr. Jeffrey W. Albers, J.D.

Independent Director

-
Gross Remuneration
  • Current Company

    Kymera Therapeutics Inc
YEAR COMPANY POSITION SALARY INCREMENT
2024 Kymera Therapeutics Inc Independent Director - -
2024 Blueprint Medicines Corp Chairman of the Board - -
2024 Spyre Therapeutics Inc. Chairman of the Board - -
2023 Blueprint Medicines Corp Chairman of the Board 526.1 K -
2023 Kymera Therapeutics Inc Independent Director 241.5 K -
2023 Aeglea BioTherapeutics Inc Director - -
2023 Spyre Therapeutics Inc. Director - -
2022 Kymera Therapeutics Inc Independent Director - -
2022 Blueprint Medicines Corp Chairman of the Board - -
2021 Kymera Therapeutics Inc Independent Director 586.1 K -17.0 %
2021 Blueprint Medicines Corp Executive Chairman of the Board - -
2020 Kymera Therapeutics Inc Independent Director 706.5 K -
2020 Blueprint Medicines Corp Director, President and Chief Executive Officer - -
2019 Blueprint Medicines Corp Director, President and Chief Executive Officer - -
2019 Kymera Therapeutics Inc Independent Director - -
2018 Blueprint Medicines Corp President, Chief Executive Officer and Director - -
2017 Blueprint Medicines Corp President, Chief Executive Officer and Director - -
2016 Blueprint Medicines Corp President, Chief Executive Officer and Director - -
2015 Blueprint Medicines Corp President, Chief Executive Officer and Director - -
2014 Blueprint Medicines Corp President, Chief Executive Officer and Director - -